US Stock MarketDetailed Quotes

FENC Fennec Pharmaceuticals

Watchlist
  • 6.550
  • +0.230+3.64%
Trading Mar 18 12:23 ET
178.76MMarket Cap-2183.33P/E (TTM)

About Fennec Pharmaceuticals Company

Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.

Company Profile

SymbolFENC
Company NameFennec Pharmaceuticals
Listing DateSep 13, 2017
Founded1996
CEOMr. Jeffrey S. Hackman
MarketNASDAQ
Employees29
Fiscal Year Ends12-31
AddressResearch Triangle Park,68 T.W. Alexander Drive
CityDurham
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27709
Phone1-919-636-4530

Company Executives

  • Name
  • Position
  • Salary
  • Jeffrey S. Hackman
  • Chief Executive Officer and Director
  • --
  • Robert Andrade
  • Chief Financial Officer and Principal Accounting Officer
  • 1.31M
  • Christiana Cioffi, M.B.A.
  • Chief Strategy Officer
  • --
  • Terry Evans
  • Chief Commercial Officer
  • --
  • Pierre S. Sayad, M.S.
  • Chief Medical Officer
  • --
  • Dr. Khalid Islam, PhD
  • Chairman of the Board
  • 225.23K
  • Rostislav Raykov
  • Director
  • 2.54M
  • Chris A. Rallis
  • Independent Director
  • 173.18K
  • Dr. Marco M. Brughera
  • Independent Director
  • 166.31K
  • Dr. Jodi A. Cook, PhD
  • Independent Director
  • 153.81K

Trending Stocks

Discussing
Chinese stock earnings surge: Will profit sustain the rally?
🎙️Discussion1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovati Show More